Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer (Q42920935)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 1, 2010
edit
Language Label Description Also known as
English
Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer
scientific article published on October 1, 2010

    Statements

    Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer (English)
    Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit